ITC Issues LEO Against Dermatological Treatment Devices
The International Trade Commission is issuing a limited exclusion order banning imports of dermatological treatment devices (ITC Inv. No. 337-TA-1356) from EndyMed Medical Ltd., it said in a June 9 notice. Additionally, the ITC set a bond in the amount…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
of 85% of the entered value of the EndyMed Pure, and 70% of the entered value of the EndyMed Pro infringing products imported during the period of presidential review, and issued cease and desist orders against the companies. The ITC terminated the investigation with respect to the four patents at issue. The order concludes in part the Section 337 investigation the ITC launched in July 2024, based on allegations by Serendia that 15 companies are importing and selling merchandise that copies its patented methods and items for treating skin tissue using bipolar electrodes in portable devices (see 2304050064). For the remaining ’444 patent, the Commission determined to remand to the ALJ for further proceedings and extended the target date to July 8.